The probability density function of patient paths compared with 1000 random paths of equivalent length indicated a highly significant subset of paths as measured by empirical P -value (see Methods).
← all excerpts
De novo individualized disease modules reveal the synthetic penetrance of genes and inform personalized treatment regimens.
1
—
—